Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Ocular side effects of anti-rheumatic medications: what a rheumatologist should know Peponis V; Kyttaris VC; Chalkiadakis SE; Bonovas S; Sitaras NMLupus 2010[May]; 19 (6): 675-82Nearly every drug may cause changes to ocular tissues through a variety of mechanisms. Medication overdoses, drug-drug interactions but also chronic administration of medications at the recommended doses may lead to ocular toxicity. The ocular side effects, screening for eye toxicity and treatment guidelines for anti-inflammatory and immunosuppressive drugs commonly used by rheumatologists are reviewed herein.|Anti-Inflammatory Agents, Non-Steroidal/adverse effects/therapeutic use[MESH]|Antimalarials/adverse effects/therapeutic use[MESH]|Antimetabolites/adverse effects/therapeutic use[MESH]|Antirheumatic Agents/*adverse effects/*therapeutic use[MESH]|Bone Density Conservation Agents/adverse effects/therapeutic use[MESH]|Diphosphonates/adverse effects/therapeutic use[MESH]|Drug Interactions[MESH]|Eye Diseases/*chemically induced[MESH]|Humans[MESH]|Rheumatic Diseases/*drug therapy[MESH]|Sulfasalazine/adverse effects/therapeutic use[MESH] |